| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 928118-13-2 | 2-Amino-6-Fluoro-4-Nitro-Phenol | |
| 928118-43-8 | 7-Chloro-1H-pyrido[3,4-b][1,4]oxazin-2(3H)-one | C7H5ClN2O2 |
| 928134-31-0 | LCI699 | |
| 928134-65-0 | LCI 699 | C13H10FN3 |
| 928136-78-1 | 4-Bromo-3-(trifluoromethoxy)benzonitrile | C8H3BrF3NO |
| 928136-82-7 | 4-(2-(tert-butyldimethylsilyloxy)ethyl)-1-trityl-1H-imidazole | |
| 928138-99-2 | Methyl 2,6-dimethyl-L-tyrosinate hydrochloride (1:1) | C12H18ClNO3 |
| 928139-31-5 | 6-Cyanopyridine-3-sulfonyl Chloride | C6H3ClN2O2S |
| 928148-51-0 | Alisol O | C32H48O5 |
| 928149-12-6 | (1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)methyl 4-methylbenzenesulfonate | C13H18O5S2 |
| 928151-78-4 | Tenacissoside F | C35H56O12 |
| 928160-90-1 | [6-(1,4-Dioxa-8-azaspiro[4.5]dec-8-yl)-3-pyridinyl]boronic acid | C12H17BN2O4 |
| 928165-59-7 | 3-Chloro-1-(4-octylphenyl)-1-propanone | C17H25ClO |
| 928196-33-2 | 3-[(1S)-1-Aminoethyl]-Benzenesulfonic Acid | C8H11NO3S |
| 928201-45-0 | 2-[[6-[(3R)-3-Amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluorobenzonitrile Trifluoroacetic Acid Salt | C20H21F4N5O4 |
| 928201-46-1 | Trelagliptin hydrochloride | C18H20FN5O2.HCl |
| 928213-43-8 | OTX008 | |
| 928292-48-2 | Methyl 2-(1H-imidazol-4-yl)ethanimidate | C6H9N3O |
| 928292-69-7 | 3,6,9,12,15,18,21,24,27,30-Decaoxadotriacontane-1,32-diamine | C22H48N2O10 |
| 928304-42-1 | 1-Ethynyl-2-Fluoro-4-Methyl-Benzene | C9H7F |
| 928313-94-4 | 2-(3,3-Diphenylpropylamino)-N,N-diphenylacetamide hydrochloride | C29H28N2O.HCl |
| 928324-59-8 | 6-Chloro-5-(trifluoromethyl)pyridine-3-sulfonyl chloride | C6H2Cl2F3NO2S |
| 928324-80-5 | 2-Chloro-5-(2-fluorophenyl)-1-[(pyridin-3-yl)sulfonyl]-1H-pyrrole-3-carboxaldehyde | C16H10ClFN2O3S |
| 928325-26-2 | 5-(2-Fluoro-3-pyridinyl)-1H-pyrrole-3-carboxaldehyde | C10H7FN2O |
| 928325-68-2 | 2-Chloro Vonoprazan | C17H15ClFN3O2S |
| 928325-82-0 | Vonoprazan impurity 21 | C17H17N3O2S .C4H4O4 |
| 928326-83-4 | BIBF-1120 | C31H33N5O4 |
| 928333-30-6 | IRAK inhibitor 2 | C17H14N4O2 |
| 928337-50-2 | 6-Methoxy-5,6-dihydro-1H-pyrazolo[1,5-b]pyrazol-3-amine | C6H10N4O |
| 928337-54-6 | N1-Methyl-1H-pyrazolo[1,5-b]pyrazole-1,4-diamine | C6H9N5 |
| 928337-56-8 | 4-Chloro-1H-pyrazolo[1,5-b]pyrazol-1-ol | C5H4ClN3O |
| 928337-57-9 | 1-Methoxy-1H-pyrazolo[1,5-b]pyrazol-2-amine | C6H8N4O |
| 928337-61-5 | N1-Methyl-1H-pyrazolo[1,5-b]pyrazole-1,2-diamine | C6H9N5 |
| 928337-70-6 | 4,6-Diamino-1H-imidazo[1,5-b]pyrazol-1-ol | C5H7N5O |
| 928337-87-5 | 1-Methoxy-1H-imidazo[1,5-b]pyrazol-2-amine | C6H8N4O |
| 928337-91-1 | N1-Methyl-1H-imidazo[1,5-b]pyrazole-1,2-diamine | C6H9N5 |
| 928338-02-7 | 3,6-Diamino-5H-imidazo[1,2-b]pyrazol-5-ol | C5H7N5O |
| 928338-06-1 | 5H-Imidazo[1,2-b]pyrazole-3,5,6-triamine | C5H8N6 |
| 928338-18-5 | 5-Methoxy-5H-imidazo[1,2-b]pyrazol-6-amine | C6H8N4O |
| 928338-22-1 | N5-Methyl-5H-imidazo[1,2-b]pyrazole-5,6-diamine | C6H9N5 |
| 928338-32-3 | 3,6-Diamino-5H-pyrazolo[5,1-c][1,2,4]triazol-5-ol | C4H6N6O |
| 928338-36-7 | 5H-Pyrazolo[5,1-c][1,2,4]triazole-3,5,6-triamine | C4H7N7 |
| 928338-47-0 | 5-Methoxy-5H-pyrazolo[5,1-c][1,2,4]triazol-6-amine | C5H7N5O |
| 928338-50-5 | N5-Methyl-5H-pyrazolo[5,1-c][1,2,4]triazole-5,6-diamine | C5H8N6 |
| 928338-64-1 | 3,5-Diamino-6H-pyrazolo[1,5-c][1,2,3]triazol-6-ol | C4H6N6O |
| 928338-69-6 | 6H-Pyrazolo[1,5-c][1,2,3]triazole-3,5,6-triamine | C4H7N7 |
| 928339-75-7 | 1,3,5-Tris(3-mercaptobutyryloxyethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione | C21H33N3O9S3 |
| 928340-97-0 | beta-D-Glucopyranose 6-(3,4,5-trihydroxybenzoate) monoglycoside with 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol | C27H26O12 |
| 928344-12-1 | AS1940477 | |
| 928615-46-7 | 5-(2-Fluorophenyl)-N-methyl-1-(2-pyridinylsulfonyl)-1H-pyrrole-3-methanamine | C17H16FN3O2S |